Synergistic antiproliferative effect of imatinib and adriamycin in platelet‐derived growth factor receptor‐expressing osteosarcoma cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|7|875-882

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.7, 2015-07, pp. : 875-882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of microRNA‐214 ameliorates hepatic fibrosis and tumor incidence in platelet‐derived growth factor C transgenic mice

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1143-1152

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of microRNA‐214 ameliorates hepatic fibrosis and tumor incidence in platelet‐derived growth factor C transgenic mice

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1143-1152

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β‐dependent manner in human osteosarcoma

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1394-1401

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma

By  

Cancer Science, Vol. 106, Iss. 8, 2015-08 ,pp. : 1016-1022

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 604-610

John Wiley & Sons Inc

Access to resources Recommend Favorite